EXONHIT

Chemical products and compositions, namely, nucleic acids attached to a solid medium for industrial and scientific use; fissile chemical elements intended for scientific research or laboratory research, namely, reagents, consumables, chemical entities and compounds; chemical preparations for nucleic acids attached to a solid medium for scientific purposes, chemical preparations for scientific analyses other than for medical or veterinary purposes; biological preparations other than for medical or veterinary purposes, namely, blood for the quantification of nucleic acid content; chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents or products for laboratory analyses, namely, nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for conducting research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, libraries of nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for leading research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, DNA fragments for decoding genes affected by diseases or for revealing the transcriptomic signature of patients affected by diseases, and DNA fragments for revealing and analyzing the expression of genes in connection with human medicine, pharmacological medicine and veterinary science

Pharmaceutical products for the treatment of diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; reagents and consumables for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents, consumables and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and, cancer; biopharmaceutical products, namely, reagents, consumables, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer ; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing Alzheimer disease and other neurodegenerative diseases and cancer, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely, probes and kits for medical and clinical diagnosis comprised of nucleic acid libraries and nucleic acids on DNA chips; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely, for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents contained in diagnostic test kits for medical use for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions

Surgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, and measuring the progression of diseases, namely, Alzheimer disease and other neurodegenerative diseases, and cancer; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus intended for medical diagnosis, namely, materials for taking blood contained in kits for taking blood samples and comprised of medical instruments for taking blood; medical instruments for taking blood, collecting of DNA for diagnosing diseases, and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers; spoons for administering medicine; specially adapted containers for the application of medicines, namely, small bags and pouches for use in administering medicines; probes for medical purposes; syringes for medical purposes

Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues and blood samples; biotechnological scientific project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology

Medical services; veterinary services; medical assistance services; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry services, namely, to provide advice in the fields of biotechnology and pharmacy; and pharmacist's services to make up prescriptions, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services